Cleared Traditional

K241915 - CareSuperb™ COVID-19 Antigen Home Test (FDA 510(k) Clearance)

Jan 2025
Decision
212d
Days
Class 2
Risk

K241915 is an FDA 510(k) clearance for the CareSuperb™ COVID-19 Antigen Home Test. This device is classified as a Over-the-counter Covid-19 Antigen Test (Class II - Special Controls, product code QYT).

Submitted by Access Bio, Inc. (Somerset, US). The FDA issued a Cleared decision on January 29, 2025, 212 days after receiving the submission on July 1, 2024.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3984. For The Rapid, Qualitative Detection Of Sars-cov-2 Virus Nucleocapsid Protein Antigen In Individuals 2 Years And Older..

Submission Details

510(k) Number K241915 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2024
Decision Date January 29, 2025
Days to Decision 212 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code QYT - Over-the-counter Covid-19 Antigen Test
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3984
Definition For The Rapid, Qualitative Detection Of Sars-cov-2 Virus Nucleocapsid Protein Antigen In Individuals 2 Years And Older.